Log in to save to my catalogue

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabo...

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9942346

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs

About this item

Full title

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs

Publisher

Korea (South): Korean Association for the Study of the Liver

Journal title

Clinical and Molecular Hepatology, 2022, 28(2), , pp.269-272

Language

English

Formats

Publication information

Publisher

Korea (South): Korean Association for the Study of the Liver

More information

Scope and Contents

Contents

[...]suppression of IL-17 inhibits activation of hepatic stellate cells and collagen production in vitro [11]. [...]treatment with anti-IL-17 antibody improved hepatic fibrosis in a NASH mice model [12]. IL-17 signaling promotes apoptosis of human megakaryocyte cells, and neutralization of IL-17 up-regulates anti-apoptotic Bcl-2 protein in megakary...

Alternative Titles

Full title

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9942346

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_9942346

Other Identifiers

ISSN

2287-2728

E-ISSN

2287-285X

DOI

10.3350/cmh.2022.0040

How to access this item